# Comparative Study of PK and BE of VM-1500FDC (Fixed-dose Combination) and Elpida® With Truvada® сo-administrated 1 Daily Fasting in Healthy Subjects

> **NCT03706924** · PHASE1 · COMPLETED · sponsor: **Viriom** · enrollment: 140 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** VM-1500FDC
- **DRUG:** Elpida®
- **DRUG:** Truvada®

## Key facts

- **NCT ID:** NCT03706924
- **Lead sponsor:** Viriom
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2018-10-12
- **Final completion:** 2018-10-12
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2018-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03706924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03706924, "Comparative Study of PK and BE of VM-1500FDC (Fixed-dose Combination) and Elpida® With Truvada® сo-administrated 1 Daily Fasting in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03706924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*